Viewing Study NCT05000450

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-01-31 @ 5:40 AM
Study NCT ID: NCT05000450
Status: TERMINATED
Last Update Posted: 2024-06-28
First Post: 2021-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Allogene Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR T View
None Cell Therapy View
None Allogeneic Cell Therapy View
None Cellular Immuno-therapy View
None AlloCAR T View
None ALLO-605 View
None ALLO-647 View
None Multiple Myeloma View